Medplus Health Subsidiary Receives Drug License Suspension Order
Medplus Health Services Limited announced that Optival Health Solutions Private Limited, a subsidiary of the company, has received a suspension order for a Drug License. The order pertains to a store located in Kalyan Nagar, Dharwad, Karnataka.According to the order received on March 27, 2026, the Drug License for the store has been suspended for three days. The suspension was issued by the Assistant Director, Drugs Control Administration, Hubli Circle, Hubli, Karnataka, citing a violation of Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
The potential financial impact of the suspension is estimated at a revenue loss of Rs 0.66 lacs.
Further details are available on the company website at www.medplusindia.com, as well as on the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com).
Manoj Kumar Srivastava, Company Secretary & Compliance Officer for Medplus Health Services Limited, made the announcement.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.